BXRX - Baudax Bio shares more than double after TeraImmune acquisition
2023-06-30 10:56:09 ET
- Baudax Bio ( NASDAQ: BXRX ) said on Friday that it had acquired TeraImmune, a Treg research company
- BXRX shares more than double, up +163.4% .
- Under the deal, TeraImmune's outstanding equity interests were exchanged for a combination of BXRX common stock, shares of newly designated convertible Series X Non-Voting Convertible Preferred Stock.
- Baudax Bio equity holders will own ~18% of the combined company.
- BXRX CEO Gerri Henwood will serve as CEO of the combined entity.
- Press Release
For further details see:
Baudax Bio shares more than double after TeraImmune acquisition